Skip to main content

Evidence gap analysis

Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Administrative reorganization in Norway came into force

Changes in the Norwegian central health administration announced by the government in May 2023 came into force on January 1, 2024. The Directorate of Health was refined as a government body with expanded responsibility in digitalization, the development of health care services, and public health. The reorganization included the following: 

  • The Directorate of Health merged with the Directorate for e-Health. The Directorate of e-Health content (coding, standards, etc.) has not yet been moved to the Directorate of Health website and will continue to be published at until further notice;
  • The Directorate of Health takes over public health tasks from the Norwegian Institute of Public Health (NIPH);
  • The health registers are moved from the Directorate of Health to NIPH;

The reorganization will provide more clarified roles and distribution of responsibilities between the various agencies. The government suggests that changes provide better support to the municipal sector, better utilization of health data, a closer link between digitization and service development, and strengthened health preparedness overall.

See the full details in Norwegian here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.